Advantages of Semaglutide: Well-established safety and efficacy data from decades of diabetes use Approved dosing pathway: gradual titration from 0.25 mg reduces GI side effects Available at Hartwater Wellness as a cash-pay service with transparent monthly pricing Lower cost than tirzepatide at therapeutic doses Considerations: Modestly lower weight loss ceiling compared to tirzepatide Gastrointestinal side effects (nausea, vomiting, diarrhea) most common during titration Tirzepatide Tirzepatide is a dual GIP/GLP-1 receptor co-agonist
Food and Drug Administration: FDA Approves First New Molecular Entity Under National Priority Voucher Program Harvard Health Publishing: How Does Ozempic Work
D., Alfonso-Cristancho, R., Conner, C., Hammer, M., & Blonde, L
Distinguishing Between a Drug Side Effect and a UC Flare One of the trickiest parts of taking a GLP-1 for people with UC is determining whether new symptoms are due to the medication or the disease flaring
Evidence suggests that GLP-1R agonists, initially developed for the treatment of DM, have therapeutic potential in the management of AD because of their multifaceted mechanism of action